GTS Securities’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,044
Closed -$494K 1574
2026
Q1
$494K Sell
1,044
-442
-30% -$223K 0.02% 753
2025
Q4
$694K Buy
1,486
+909
+158% +$422K 0.02% 609
2025
Q3
$246K Sell
577
-255
-31% -$98.8K 0.01% 1168
2025
Q2
$319K Sell
832
-436
-34% -$157K 0.01% 886
2025
Q1
$438K Buy
1,268
+338
+36% +$109K 0.02% 752
2024
Q4
$279K Sell
930
-1,755
-65% -$613K 0.01% 924
2024
Q3
$1.09M Buy
2,685
+1,530
+132% +$560K ﹤0.01% 2085
2024
Q2
$371K Buy
+1,155
New +$375K ﹤0.01% 2949
2024
Q1
Sell
-3,166
Closed -$967K 4104
2023
Q4
$857K Sell
3,166
-5,370
-63% -$1.33M ﹤0.01% 2306
2023
Q3
$2.1M Buy
+8,536
New +$2.34M ﹤0.01% 1478

Other funds holding HCA

GTS Securities's HCA Position: Q2 2026 in Review

GTS Securities sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 1,044 shares — an estimated $494K sold.

GTS Securities first reported a position in HCA in Q3 2023 and held it in 10 quarters. The position peaked at $2.1M in Q3 2023. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • GTS Securities reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 1,044 HCA Healthcare shares in Q2 2026, an estimated $494K.
  • GTS Securities first reported a position in HCA Healthcare in Q3 2023 and held it in 10 quarters.
  • GTS Securities's HCA Healthcare position peaked at $2.1M in Q3 2023.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.